Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07901088
PHASE1
A Bioequivalence and Safety Study of AJU-B718 and B718R in Healthy Adult Volunteers Under Fasting Conditions
Sponsor: AJU Pharm Co., Ltd.
View on ClinicalTrials.gov
Summary
To evaluate the bioequivalence and safety of AJU-B718 and B718R in Healthy Adults.
Official title: A Randomized, Open-Label, Fasting, Single-Dose, Oral, 2-Group, 4-Period, Replicate Crossover Study to Evaluate the Bioequivalence and Safety of AJU-B718 and B718R in Healthy Adult Volunteers
Key Details
Gender
All
Age Range
19 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2026-11
Completion Date
2026-12
Last Updated
2026-10-28
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
Test Drug
AJU-B718
DRUG
Reference Drug
B718R
Locations (1)
H+ Yangji Hospital
Seoul, Seoul, South Korea